About
Overview
Company Leadership
Science
Technology Platform
Scientific Publications
Pipeline
Overview
CF101
CF102
CF602
Investor Information
Overview
News / Events
Company Information
Financial Information
Stock Information
SEC Filings
Corporate Governance
Shareholders Meetings
Contact Us
Directions
Investor Information
Overview
News / Events
Press Releases
In The News
Research
Events Calendar
Presentations
Email Alerts
Company Information
Profile
Management
IR Contacts
FAQ
Financial Information
Quarterly & Annual Reports
Stock Information
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Shareholders Meetings
Email Alerts
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Feb 10, 2020 2:48 PM EST
Can-Fite BioPharma Announces Pricing of $5 Million Public Offering
Feb 3, 2020 7:30 AM EST
Can-Fite Completes 50% Patient Enrollment in Phase III Rheumatoid Arthritis Study & Implements Interim Analysis
Jan 16, 2020 7:00 AM EST
Can-Fite and Univo Pharmaceuticals Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects
Jan 9, 2020 9:10 AM EST
Can-Fite Announces Exercise of Warrants for Cash Proceeds of $2.4 Million
Jan 7, 2020 8:20 AM EST
Data from the Phase II Liver Cancer Study with Namodenoson will be presented at the ISCORT Conference by Dr. Stemmer
Jan 6, 2020 7:00 AM EST
Can-Fite CEO Issues Letter to Shareholders
Jan 3, 2020 7:00 AM EST
New Data From Hadassah Medical Center Lab Show Can-Fite’s Namodenoson Induces Weight Loss
Dec 26, 2019 7:00 AM EST
Golan Bitton Univo Pharmaceutical CEO Elected to the Can-Fite Board: A Strategic Partnership with Univo to Develop Cannabinoid-Based Products is Ongoing
Dec 9, 2019 8:15 AM EST
Can-Fite Completes 50% Patient Enrollment in its Phase III Psoriasis Trial
Dec 5, 2019 7:00 AM EST
Can-Fite to Attend BioFIT 2019 Conference in Europe with Focus on Partnering Meetings for Namodenoson in NASH
<< Previous
1
2
3
4
5
6
7
8
9
10
...30
Next >>
Show All